Peking University People's Hospital
Clinical trials sponsored by Peking University People's Hospital, explained in plain language.
-
CAR-T showdown: new hope to stop Leukemia's return
Disease control Recruiting nowThis study compares two approaches for patients with B-cell acute lymphoblastic leukemia (B-ALL) who still show tiny amounts of cancer cells after a stem cell transplant. Researchers will test whether a personalized immune cell therapy (CAR-T) works better than standard chemother…
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New 'Double-Target' cell therapy tested for tough leukemia cases
Disease control Recruiting nowThis study is testing a new type of CAR-T cell therapy designed to attack leukemia cells using two targets (CD19 and CD22) at once. It aims to see if this approach is safe and effective for patients aged 12-65 whose B-cell acute lymphoblastic leukemia has come back or hasn't resp…
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cell therapy targets stubborn leukemia after transplant
Disease control Recruiting nowThis early-phase study is testing a new type of CAR-T cell therapy for patients with T-cell leukemia or lymphoma. The goal is to see if it is safe and effective at eliminating tiny amounts of leftover cancer cells that remain after a patient has already received a stem cell trans…
Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test 'Double-Punch' cell therapy for Tough-to-Treat lymphoma
Disease control Recruiting nowThis early-phase study is testing the safety and effectiveness of a new type of CAR-T cell therapy that targets two proteins (CD19 and CD20) on lymphoma cells. It is for adults with aggressive B-cell lymphoma that has come back or hasn't responded to at least two prior treatments…
Phase: EARLY_PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Freeze and heat: new hope for breast cancer patients who Can't have surgery
Disease control Recruiting nowThis study is testing a minimally invasive treatment that uses extreme cold and heat to destroy breast cancer tumors. It is for patients who cannot have or choose not to have standard surgery. Researchers will follow 200 participants for over 5 years to see how safe the treatment…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Blood test could predict which amyloidosis patients will respond best to treatment
Disease control Recruiting nowThis study aims to determine if early blood test results can predict which patients with AL amyloidosis will achieve complete remission with daratumumab-based treatment. Researchers will follow 50 patients receiving standard therapy to see if blood measurements taken just one wee…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Doctors test skin cell transplants to restore color in vitiligo
Disease control Recruiting nowThis study is testing a surgical procedure that transplants a patient's own healthy skin cells into areas affected by vitiligo, aiming to restore skin color. It will enroll 30 people with stable vitiligo that hasn't responded well to medications or light therapy. Researchers will…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can diet changes help control cancer? study tests fasting vs. Low-Calorie plans
Disease control Recruiting nowThis study is testing whether specific diet plans can help overweight patients with endometrial cancer who are trying to preserve their fertility. Researchers are comparing intermittent fasting, a low-energy balanced diet, and standard self-care to see which approach best helps w…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug combo aims for Longer-Lasting relief in blood platelet disorder
Disease control Recruiting nowThis study is testing if adding a drug called teriflunomide to the standard first treatment (high-dose dexamethasone) works better for adults newly diagnosed with ITP, a condition where the immune system attacks blood platelets. The goal is to see if the combination helps keep pl…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New shot aims to stop hepatitis b from coming back
Disease control Recruiting nowThis study is testing if a treatment called hepatitis B immunoglobulin (HBIG) can help patients stay cured of chronic hepatitis B. It will involve 132 people who have already cleared the virus with a previous treatment. Researchers want to see if this immune-boosting shot prevent…
Phase: EARLY_PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug duo tested for Tough-to-Treat bone cancer
Disease control Recruiting nowThis study is testing a combination of two drugs, apatinib and liposomal irinotecan, for people with advanced osteosarcoma (a type of bone cancer) that has come back or spread after standard chemotherapy. The main goals are to find the safest and most effective dose of the two dr…
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Can losing weight help fight uterine cancer?
Disease control Recruiting nowThis study is testing if a structured weight management program can help control cancer and improve health for overweight patients with endometrial (uterine) cancer who are receiving treatment to preserve their fertility. Researchers will compare weight management against standar…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Blood test could spare breast cancer patients from harsh chemo
Disease control Recruiting nowThis study is testing a personalized approach to reduce chemotherapy for women with a common type of early-stage breast cancer. It uses a simple blood test to see if a targeted pill (dalpiciclib) combined with hormone therapy works as well as standard chemo before surgery. The go…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Freeze and burn: new breast cancer treatment aims to replace surgery
Disease control Recruiting nowThis study is testing a new, less invasive treatment for early-stage breast cancer. It compares a technique that freezes and heats the tumor (cryo-thermal ablation) against standard breast-conserving surgery. The main goal is to see if the new method is as effective at preventing…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Massive 10,000-Person study tests common arthritis injection
Disease control Recruiting nowThis study aims to see how well and how safely an injected form of the drug methotrexate works for people with rheumatoid arthritis in everyday medical practice. It will follow 10,000 adult patients in China who are already starting this treatment. The main goal is to measure how…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
AI spots bone weakness in your old scans
Diagnosis Recruiting nowThis study is testing a new computer program that can check your bone health using CT scans you've already had for other reasons. Researchers will use scans from 3,000 adults to see if the AI can accurately estimate 'bone age' and spot early signs of osteoporosis. The goal is to …
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC
-
Glowing dye helps surgeons see lung cancer more clearly
Diagnosis Recruiting nowThis study is testing two new imaging methods to help doctors better see lung cancer tumors. Before surgery, patients get a special PET scan. During surgery, doctors use a fluorescent dye that makes tumor tissue glow under special light. The goal is to see if these methods can mo…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC
-
AI doctor for bones: new study aims to spot arthritis and weak bones earlier
Diagnosis Recruiting nowThis study is testing a new artificial intelligence (AI) system designed to help doctors diagnose and determine the severity of two common age-related conditions: osteoporosis (weak bones) and osteoarthritis (joint wear-and-tear). The AI will analyze X-rays, CT scans, and MRIs fr…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Mar 17, 2026 13:10 UTC
-
New test aims to predict Cancer's return after transplant
Knowledge-focused Recruiting nowThis study is testing a new laboratory method to see if it can better predict which patients with a blood cancer called myelodysplastic syndrome (MDS) might relapse after receiving a stem cell transplant. Researchers will track 163 patients after their transplant to see if the ne…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 19:56 UTC
-
Tracking 500 cancer patients to map China's immunotherapy landscape
Knowledge-focused Recruiting nowThis study aims to understand how newly diagnosed multiple myeloma patients in China respond to first-line immunotherapy treatments in real-world hospital settings. Researchers will follow 500 patients for one year to track their treatment patterns and outcomes. The goal is to ga…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 19:55 UTC
-
New blood test aims to catch leukemia before it returns in kids
Knowledge-focused Recruiting nowThis study is testing a new laboratory method to detect very small numbers of leftover leukemia cells in the blood and bone marrow of children. The goal is to better predict which children are at high risk of their cancer coming back after initial treatment. If successful, this c…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Researchers race to build early warning system for High-Risk pregnancies
Knowledge-focused Recruiting nowThis study aims to create and test a prediction tool to identify which pregnant women with aplastic anemia are at highest risk for serious complications. Aplastic anemia is a rare blood disorder that makes pregnancy very dangerous for both mother and baby. Researchers will follow…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test new blood test to catch lung Cancer's return
Knowledge-focused Recruiting nowThis study aims to develop a new, non-invasive way to monitor lung cancer patients after surgery to see if the cancer might come back. Researchers will collect blood samples from 100 patients who have had lung cancer surgery and analyze them using advanced computer programs. The …
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Massive study launches to track heart risks for 10,000 stem cell transplant patients
Knowledge-focused Recruiting nowThis study aims to understand the long-term heart health risks for people who have received a stem cell transplant. Researchers will follow 10,000 transplant patients from multiple hospitals, collecting detailed information about their health and any heart-related problems that o…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC